Want to join the conversation?
$KSS 2Q15 Call: We successfully amended and extended our revolver for an additional two years from 2018 to 2020. There were no changes to the financial covenants included in the agreement. Absent the effect of loss in our extinguishment of debt, we now expect our earnings per diluted share to be at the low end of our previous guidance of $4.40-4.60
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)